Table 5. Patients characteristics of the TMA cohort (n=245).
| Characteristic | n=245 | Value | ||
|---|---|---|---|---|
| Follow up | – mo | (SD) | 60.0 | (50.5) |
| Age at diagnosis | – year | (SD) | 71.7 | (13.1) |
| FIGO stage | – n | (%) | ||
| Stage 1 | 51 | (21) | ||
| Stage 2 | 94 | (38) | ||
| Stage 3 | 67 | (27) | ||
| Stage 4 | 33 | (13) | ||
| Lymph node metastases | – n | (%) | 92 | (43) |
| Extracapsular growth | – n | (%) | 40 | (16) |
| Tumor size | – mm | (SD) | 33.0 | (17.2) |
| Infiltration depth | – mm | (IQR) | 7.0 | (3.8-10.0) |
| Positive resection margins | – n(%) | 21 | (8.6) | |
| Disease status | – n | (%) | ||
| Complete remission | 154 | (63) | ||
| Local recurrence | 50 | (20) | ||
| Regional recurrence | 14 | (6) | ||
| Distant recurrence | 6 | (2) | ||
| Died | 120 | (49) | ||
| Disease specific death | 50 | (20) | ||
| 5-yr Overall survival | – % | (SD) | 59.6 | (3.0) |
| 5-yr Disease specific survival | – % | (SD) | 78.2 | (2.6) |
| 5-yr Disease free survival | – % | (SD) | 64.5 | (3.0) |